Conditional survival nomogram for dynamic prognostic prediction in older women with surgically treated breast cancer

Prognostic estimates established at breast cancer diagnosis may become less informative as patients survive longer, particularly among older women with substantial competing mortality risks. This study aimed to develop and internally validate a dynamic conditional survival (CS) nomogram for predicting breast cancer-specific survival (BCSS) in surgically treated women aged ≥70 years. Data were obtained from the Surveillance, Epidemiology, and End Results (SEER) database for patients diagnosed between 2010 and 2015. The 44,354 eligible patients were randomly assigned to training (n = 31,047) and internal validation (n = 13,307) cohorts. A random survival forest (RSF) algorithm was used to select prognostic variables, which were incorporated into a multivariable Cox regression model to construct a nomogram combining conventional and conditional BCSS estimates. Model performance was evaluated using the concordance index (C-index), time-dependent receiver operating characteristic curves, calibration analysis, and decision curve analysis. The RSF algorithm selected age, T stage, N stage, M stage, histological grade, and molecular subtype as independent predictors of BCSS. The estimated probability of surviving to 10 years increased from 88% at diagnosis to 89%, 92%, 95%, and 97% after surviving 1, 3, 5, and 7 years, respectively. The model achieved C-indices of 0.833 and 0.830 in the training and validation cohorts, respectively, with time-dependent areas under the curve ranging from 0.841 to 0.882. Calibration was satisfactory, and the nomogram provided greater net benefit than tumor-node-metastasis staging alone. This internally validated nomogram provides individualized, time-updated BCSS estimates and may support dynamic risk stratification during long-term follow-up, although external validation is required before clinical implementation.

Authors

Institutions

Publication Details

Journal
Biomolecules and Biomedicine
Published
2026-07-24
DOI
https://doi.org/10.17305/bb.2026.14576
Primary Topic
Breast Cancer Treatment Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Conditional survival nomogram for dynamic prognostic prediction in older women with surgically treated breast cancer

Haolong Niu, Jinying Zhang
Biomolecules and Biomedicine
Breast Cancer Treatment Studies
article

Conditional survival nomogram for dynamic prognostic prediction in older women with surgically treated breast cancer

Haolong Niu, Jinying Zhang
article en

Abstract

Prognostic estimates established at breast cancer diagnosis may become less informative as patients survive longer, particularly among older women with substantial competing mortality risks. This study aimed to develop and internally validate a dynamic conditional survival (CS) nomogram for predicting breast cancer-specific survival (BCSS) in surgically treated women aged ≥70 years. Data were obtained from the Surveillance, Epidemiology, and End Results (SEER) database for patients diagnosed between 2010 and 2015. The 44,354 eligible patients were randomly assigned to training (n = 31,047) and internal validation (n = 13,307) cohorts. A random survival forest (RSF) algorithm was used to select prognostic variables, which were incorporated into a multivariable Cox regression model to construct a nomogram combining conventional and conditional BCSS estimates. Model performance was evaluated using the concordance index (C-index), time-dependent receiver operating characteristic curves, calibration analysis, and decision curve analysis. The RSF algorithm selected age, T stage, N stage, M stage, histological grade, and molecular subtype as independent predictors of BCSS. The estimated probability of surviving to 10 years increased from 88% at diagnosis to 89%, 92%, 95%, and 97% after surviving 1, 3, 5, and 7 years, respectively. The model achieved C-indices of 0.833 and 0.830 in the training and validation cohorts, respectively, with time-dependent areas under the curve ranging from 0.841 to 0.882. Calibration was satisfactory, and the nomogram provided greater net benefit than tumor-node-metastasis staging alone. This internally validated nomogram provides individualized, time-updated BCSS estimates and may support dynamic risk stratification during long-term follow-up, although external validation is required before clinical implementation.

Biomolecules and Biomedicine
Shandong University of Aeronautics (CN)
Good health and well-being
Openalex Percentile: Top 11%
Breast Cancer Treatment Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.